Found: 6
Select item for more details and to access through your institution.
Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2014, v. 18, p. 11
- By:
- Publication type:
- Article
Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2010, v. 14, n. 12, p. 1015
- By:
- Publication type:
- Article
Leukocyte Interferon Alpha Early Retreatment for Child A HCV Genotype 1b-Infected Cirrhotics Intolerant to Pegylated Interferons.
- Published in:
- Infection, 2009, v. 37, n. 3, p. 210, doi. 10.1007/s15010-008-8164-2
- By:
- Publication type:
- Article
*-Graded Capelli polynomials and their asymptotics.
- Published in:
- International Journal of Algebra & Computation, 2022, v. 32, n. 6, p. 1179, doi. 10.1142/S0218196722500503
- By:
- Publication type:
- Article
DIRECT-ACTING ANTIVIRALS DURING OR AFTER IMMUNO-CHEMOTHERAPY IN HEPATITIS C VIRUS-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 194, doi. 10.1002/hon.2438_57
- By:
- Publication type:
- Article
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 7, p. 688, doi. 10.1111/apt.14256
- By:
- Publication type:
- Article